About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Swine Healthcare Market Size, Share & Growth Analysis Report | 2031
Swine Healthcare Market

Swine Healthcare Market Size, Share & Trends Analysis Report By Product (Diagnostic Tests, Therapeutics), By Disease (Exudative Dermatitis (Greasy Pig Disease), Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI3444DR
Last Updated : July 13, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Swine Healthcare Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Diagnostic Tests
        1. By Value
      3. Therapeutics
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Exudative Dermatitis (Greasy Pig Disease)
        1. By Value
      3. Coccidiosis, Respiratory Diseases
        1. By Value
      4. Swine Dysentery
        1. By Value
      5. Porcine Parvovirus
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Diagnostic Tests
        1. By Value
      3. Therapeutics
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Exudative Dermatitis (Greasy Pig Disease)
        1. By Value
      3. Coccidiosis, Respiratory Diseases
        1. By Value
      4. Swine Dysentery
        1. By Value
      5. Porcine Parvovirus
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Diagnostic Tests
          1. By Value
        3. Therapeutics
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Exudative Dermatitis (Greasy Pig Disease)
          1. By Value
        3. Coccidiosis, Respiratory Diseases
          1. By Value
        4. Swine Dysentery
          1. By Value
        5. Porcine Parvovirus
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Diagnostic Tests
        1. By Value
      3. Therapeutics
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Exudative Dermatitis (Greasy Pig Disease)
        1. By Value
      3. Coccidiosis, Respiratory Diseases
        1. By Value
      4. Swine Dysentery
        1. By Value
      5. Porcine Parvovirus
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Diagnostic Tests
          1. By Value
        3. Therapeutics
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Exudative Dermatitis (Greasy Pig Disease)
          1. By Value
        3. Coccidiosis, Respiratory Diseases
          1. By Value
        4. Swine Dysentery
          1. By Value
        5. Porcine Parvovirus
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Diagnostic Tests
        1. By Value
      3. Therapeutics
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Exudative Dermatitis (Greasy Pig Disease)
        1. By Value
      3. Coccidiosis, Respiratory Diseases
        1. By Value
      4. Swine Dysentery
        1. By Value
      5. Porcine Parvovirus
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Diagnostic Tests
          1. By Value
        3. Therapeutics
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Exudative Dermatitis (Greasy Pig Disease)
          1. By Value
        3. Coccidiosis, Respiratory Diseases
          1. By Value
        4. Swine Dysentery
          1. By Value
        5. Porcine Parvovirus
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Diagnostic Tests
        1. By Value
      3. Therapeutics
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Exudative Dermatitis (Greasy Pig Disease)
        1. By Value
      3. Coccidiosis, Respiratory Diseases
        1. By Value
      4. Swine Dysentery
        1. By Value
      5. Porcine Parvovirus
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Diagnostic Tests
          1. By Value
        3. Therapeutics
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Exudative Dermatitis (Greasy Pig Disease)
          1. By Value
        3. Coccidiosis, Respiratory Diseases
          1. By Value
        4. Swine Dysentery
          1. By Value
        5. Porcine Parvovirus
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Diagnostic Tests
        1. By Value
      3. Therapeutics
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Exudative Dermatitis (Greasy Pig Disease)
        1. By Value
      3. Coccidiosis, Respiratory Diseases
        1. By Value
      4. Swine Dysentery
        1. By Value
      5. Porcine Parvovirus
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Diagnostic Tests
          1. By Value
        3. Therapeutics
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Exudative Dermatitis (Greasy Pig Disease)
          1. By Value
        3. Coccidiosis, Respiratory Diseases
          1. By Value
        4. Swine Dysentery
          1. By Value
        5. Porcine Parvovirus
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Swine Healthcare Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Boehringer Ingelheim GmbH
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Ceva Animal Health Inc.
    3. Elanco
    4. IDVet
    5. Merck & Co Inc.
    6. Veto quinol SA
    7. Virbac
    8. Zoetis Animal Healthcare
    9. IDEXX Laboratories Inc.
    10. Phibro Animal Health
    11. Huvepharma
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Connected Healthcare Market Size and Trends The global connected healthcare market size was valued at USD 64.06 billion in 2022 and is projected to reach USD 574.44 billion by 2031, growing at a CAGR of 27.60% during the forecast period (2023–2031).
Buy Now
Global Report
IoT Healthcare Market Size The global IoT healthcare market size was valued at USD 141.66 billion in 2024 and is expected to grow from USD 168.95 billion in 2025 to reach USD 691.86 billion by 2033, growing at a CAGR of 
Buy Now
Global Report
The global smart healthcare market size was valued at USD 196.23 billion in 2023. It is expected to reach USD 609.01 billion in 2032, growing at a CAGR of 13.41% over the forecast period (2024-32). The adoption of electronic health records (EHRs), he
Buy Now
Global Report
Smart Home Healthcare Market Size & Trends The global smart home healthcare market size was valued at USD 5.88 billion in 2024 and It is projected to reach from USD 6.40 billion in 2025 to USD 12.71 billion by 2033, growing a
Buy Now
Global Report
VR in Healthcare Market Size & Trends The global VR in healthcare market size was valued at USD 3.91 Billion in 2024 and is projected to reach from USD 5.27 Billion in 2025 to USD 57.54 Billion by 2033, registering a CAGR of
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.